Early lymphocyte recovery following autologous peripheral stem cell transplantation is associated with better survival in younger patients with lymphoproliferative disorders

M. R. Boulassel, A. L. Herr, M. D. Deb Edwardes, A. Galal, S. Lachance, P. Laneuville, J. P. Routy

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Early absolute lymphocyte count (ALC) has become an important end point for engraftment in patients undergoing autologous peripheral stem cell transplantation (APSCT). In this retrospective study, we evaluate the prognostic significance of early recovery of ALC (≥ 0.5 cells × 10 9/l on or before day 15) following APSCT in predicting transplant outcome in 72 patients with lymphoproliferative disorders, including non-Hodgkin's lymphoma (n = 30), Hodgkin's lymphoma (n = 8) and multiple myeloma (n = 34). The median quantities of CD34 + stem cells and lymphocytes infused were 4.97 10 6/kg (range 0.64-11.7) and 11.3 × 10 7/kg (range 1.11-110) respectively. After a median follow-up of 18 months (range 2-68), 28 patients had experienced a relapse and 16 had died. Of the 72 patients, 27 (37%) demonstrated early recovery of ALC. Early recovery of ALC was strongly associated with long-term overall and disease-free survival in patients aged less than 50 years (P < 0.001). In both univariate and multivariate survival analyses, a shorter time from diagnosis to APSCT was associated with early recovery of ALC (P = 0.03). These findings indicate that early recovery of ALC may contribute to longer survival in younger patients with lymphoproliferative disorders. A shorter time from diagnosis to APSCT may favor recovery of ALC independent of the infused stem cell or lymphocyte doses.

Original languageEnglish
Pages (from-to)165-170
Number of pages6
JournalHematology
Volume11
Issue number3
DOIs
Publication statusPublished - Jun 2006

Fingerprint

Peripheral Blood Stem Cell Transplantation
Lymphoproliferative Disorders
Lymphocyte Count
Lymphocytes
Survival
Stem Cells
Survival Analysis
Multiple Myeloma
Hodgkin Disease
Non-Hodgkin's Lymphoma
Disease-Free Survival
Multivariate Analysis
Retrospective Studies
Transplants
Recurrence

Keywords

  • Autologous stem cell transplantation
  • Lymphocyte recovery
  • Lymphoproliferative disorders
  • Survival

ASJC Scopus subject areas

  • Hematology

Cite this

Early lymphocyte recovery following autologous peripheral stem cell transplantation is associated with better survival in younger patients with lymphoproliferative disorders. / Boulassel, M. R.; Herr, A. L.; Deb Edwardes, M. D.; Galal, A.; Lachance, S.; Laneuville, P.; Routy, J. P.

In: Hematology, Vol. 11, No. 3, 06.2006, p. 165-170.

Research output: Contribution to journalArticle

Boulassel, M. R. ; Herr, A. L. ; Deb Edwardes, M. D. ; Galal, A. ; Lachance, S. ; Laneuville, P. ; Routy, J. P. / Early lymphocyte recovery following autologous peripheral stem cell transplantation is associated with better survival in younger patients with lymphoproliferative disorders. In: Hematology. 2006 ; Vol. 11, No. 3. pp. 165-170.
@article{3465d5a45bc54c25b77169ddcccd9f6a,
title = "Early lymphocyte recovery following autologous peripheral stem cell transplantation is associated with better survival in younger patients with lymphoproliferative disorders",
abstract = "Early absolute lymphocyte count (ALC) has become an important end point for engraftment in patients undergoing autologous peripheral stem cell transplantation (APSCT). In this retrospective study, we evaluate the prognostic significance of early recovery of ALC (≥ 0.5 cells × 10 9/l on or before day 15) following APSCT in predicting transplant outcome in 72 patients with lymphoproliferative disorders, including non-Hodgkin's lymphoma (n = 30), Hodgkin's lymphoma (n = 8) and multiple myeloma (n = 34). The median quantities of CD34 + stem cells and lymphocytes infused were 4.97 10 6/kg (range 0.64-11.7) and 11.3 × 10 7/kg (range 1.11-110) respectively. After a median follow-up of 18 months (range 2-68), 28 patients had experienced a relapse and 16 had died. Of the 72 patients, 27 (37{\%}) demonstrated early recovery of ALC. Early recovery of ALC was strongly associated with long-term overall and disease-free survival in patients aged less than 50 years (P < 0.001). In both univariate and multivariate survival analyses, a shorter time from diagnosis to APSCT was associated with early recovery of ALC (P = 0.03). These findings indicate that early recovery of ALC may contribute to longer survival in younger patients with lymphoproliferative disorders. A shorter time from diagnosis to APSCT may favor recovery of ALC independent of the infused stem cell or lymphocyte doses.",
keywords = "Autologous stem cell transplantation, Lymphocyte recovery, Lymphoproliferative disorders, Survival",
author = "Boulassel, {M. R.} and Herr, {A. L.} and {Deb Edwardes}, {M. D.} and A. Galal and S. Lachance and P. Laneuville and Routy, {J. P.}",
year = "2006",
month = "6",
doi = "10.1080/10245330600667559",
language = "English",
volume = "11",
pages = "165--170",
journal = "Hematology",
issn = "1024-5332",
publisher = "Taylor and Francis Ltd.",
number = "3",

}

TY - JOUR

T1 - Early lymphocyte recovery following autologous peripheral stem cell transplantation is associated with better survival in younger patients with lymphoproliferative disorders

AU - Boulassel, M. R.

AU - Herr, A. L.

AU - Deb Edwardes, M. D.

AU - Galal, A.

AU - Lachance, S.

AU - Laneuville, P.

AU - Routy, J. P.

PY - 2006/6

Y1 - 2006/6

N2 - Early absolute lymphocyte count (ALC) has become an important end point for engraftment in patients undergoing autologous peripheral stem cell transplantation (APSCT). In this retrospective study, we evaluate the prognostic significance of early recovery of ALC (≥ 0.5 cells × 10 9/l on or before day 15) following APSCT in predicting transplant outcome in 72 patients with lymphoproliferative disorders, including non-Hodgkin's lymphoma (n = 30), Hodgkin's lymphoma (n = 8) and multiple myeloma (n = 34). The median quantities of CD34 + stem cells and lymphocytes infused were 4.97 10 6/kg (range 0.64-11.7) and 11.3 × 10 7/kg (range 1.11-110) respectively. After a median follow-up of 18 months (range 2-68), 28 patients had experienced a relapse and 16 had died. Of the 72 patients, 27 (37%) demonstrated early recovery of ALC. Early recovery of ALC was strongly associated with long-term overall and disease-free survival in patients aged less than 50 years (P < 0.001). In both univariate and multivariate survival analyses, a shorter time from diagnosis to APSCT was associated with early recovery of ALC (P = 0.03). These findings indicate that early recovery of ALC may contribute to longer survival in younger patients with lymphoproliferative disorders. A shorter time from diagnosis to APSCT may favor recovery of ALC independent of the infused stem cell or lymphocyte doses.

AB - Early absolute lymphocyte count (ALC) has become an important end point for engraftment in patients undergoing autologous peripheral stem cell transplantation (APSCT). In this retrospective study, we evaluate the prognostic significance of early recovery of ALC (≥ 0.5 cells × 10 9/l on or before day 15) following APSCT in predicting transplant outcome in 72 patients with lymphoproliferative disorders, including non-Hodgkin's lymphoma (n = 30), Hodgkin's lymphoma (n = 8) and multiple myeloma (n = 34). The median quantities of CD34 + stem cells and lymphocytes infused were 4.97 10 6/kg (range 0.64-11.7) and 11.3 × 10 7/kg (range 1.11-110) respectively. After a median follow-up of 18 months (range 2-68), 28 patients had experienced a relapse and 16 had died. Of the 72 patients, 27 (37%) demonstrated early recovery of ALC. Early recovery of ALC was strongly associated with long-term overall and disease-free survival in patients aged less than 50 years (P < 0.001). In both univariate and multivariate survival analyses, a shorter time from diagnosis to APSCT was associated with early recovery of ALC (P = 0.03). These findings indicate that early recovery of ALC may contribute to longer survival in younger patients with lymphoproliferative disorders. A shorter time from diagnosis to APSCT may favor recovery of ALC independent of the infused stem cell or lymphocyte doses.

KW - Autologous stem cell transplantation

KW - Lymphocyte recovery

KW - Lymphoproliferative disorders

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=33748496886&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748496886&partnerID=8YFLogxK

U2 - 10.1080/10245330600667559

DO - 10.1080/10245330600667559

M3 - Article

VL - 11

SP - 165

EP - 170

JO - Hematology

JF - Hematology

SN - 1024-5332

IS - 3

ER -